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Tumor-induced remote ECM 
network orientation steers 
angiogenesis
Hayri E. Balcioglu, Bob van de Water & Erik H. J. Danen
Tumor angiogenesis promotes tumor growth and metastasis. Here, we use automated sequential 
microprinting of tumor and endothelial cells in extracellular matrix (ECM) scaffolds to study its 
mechanical aspects. Quantitative reflection microscopy shows that tumor spheroids induce radial 
orientation of the surrounding collagen fiber network up to a distance of five times their radius. Across a 
panel of ~20 different human tumor cell lines, remote collagen orientation is correlated with local tumor 
cell migration behavior. Tumor induced collagen orientation requires contractility but is remarkably 
resistant to depletion of collagen-binding integrins. Microvascular endothelial cells undergo directional 
migration towards tumor spheroids once they are within the tumor-oriented collagen fiber network. 
Laser ablation experiments indicate that an intact physical connection of the oriented network with 
the tumor spheroid is required for mechanical sensing by the endothelial cells. Together our findings 
indicate that, in conjunction with described activities of soluble angiogenic factors, remote physical 
manipulation of the ECM network by the tumor can help to steer angiogenesis.
Tumor-associated angiogenesis is one of the hallmarks of cancer1,2. The chemotactic aspect of this pathology has 
been well studied. Oncogenic signaling pathways and hypoxia occurring in tumors activate the release of growth 
factors, such as vascular endothelial growth factor (VEGF), which triggers the formation of new microvascular 
sprouts from pre-existing vessels. Inhibitors against this paracrine interaction, targeting mainly the VEGF recep-
tor (VEGFR) on endothelial cells, have entered the clinic3,4.
Angiogenesis involves proliferation and migration of endothelial cells5. During angiogenesis, endothelial cells 
migrate through a 3D extracellular matrix (ECM) network that is rich in collagen. Migration efficiency and the 
mode of migration (e.g. the extent of integrin-dependency and the requirement of matrix metalloproteases) are 
determined by ECM properties including ligand density, stiffness, fiber crosslinking, and pore size6–8. These ECM 
properties are typically altered in tumor areas; e.g. ECM stiffening has been observed in tumor tissue9,10.
The ECM network may control angiogenesis in several ways. First, it acts as an organizing platform for growth 
factor distribution, activation, and presentation11. In vitro assays have shown that tissue deformation can regulate 
angiogenesis through spatial organization of activity of the VEGF pathway12. Additionally, cells receive mechani-
cal cues from the ECM through integrin-based cell-matrix adhesions13–15. In vivo studies have demonstrated that 
angiogenesis is an integral response to chemical and mechanical cues16.
Here we use sequential microprinting of tumor and microvascular endothelial cells to investigate their 
mechanical interaction through ECM scaffolds. We use quantitative reflection microscopy analysis to study 
tumor-induced collagen orientation. We show that tumor spheroids can orient a fibrillar collagen network 
to a distance of up to 5 times the tumor radius – far beyond the area of tumor expansion and cell migration. 
Furthermore, we demonstrate that microvascular endothelial cells sense and respond to such orientation pro-
vided that the oriented ECM is physically connected to the tumor spheroid. Together, our data indicates that 
ECM network reorientation acts as a remote mechanical cue to steer angiogenesis.
Results
Tumor spheroids in 3D collagen induce the orientation of surrounding collagen. 4T1 breast can-
cer spheroids were generated by cell microprinting in collagen gels (Fig. 1a) and their outgrowth and migration 
was monitored after 48 hours (Fig. 1b). A spheroid mask was generated to define the final spheroid area including 
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spheroid core and migrated cells (Fig. 1c). Reflection microscopy was performed to analyze the collagen network 
surrounding this final spheroid area (Fig. 1d). In 2 days the tumor spheroid radius (including core and migrated 
cells) increased ~4-fold (Fig. 1a,b). Concomitantly, reflection microscopy showed a denser fibrillar collagen net-
work surrounding the tumor expansion region (Figs 1d and 2a). Quantitative image analysis showed an increase 
in collagen fibers with an orientation parameter ~1 (dark red; denoting collagen directed radially towards the 
tumor spheroid center) close to the spheroid boundary (Fig. 2a). By contrast, in areas distant from the spheroid, 
the number of fibers with an orientation parameter ~1 equaled the number of fibers with an orientation parame-
ter ~0 (dark blue; denoting collagen oriented tangential to the tumor spheroid radius) (Fig. 2a). Quantification of 
collagen fiber orientation throughout the gel relative to the distance from the final tumor spheroid edge (dashed 
red circle in Fig. 1c,d) indicated that tumor spheroids that expanded from an average radius of 116 ± 21 μm to 
527 ± 54 μm had caused radial orientation of collagen fibers up to 2.65 mm from the spheroid edge (i.e. 95% 
confidence interval > 0.5 indicating orientation was significantly different from random) (Fig. 2b). Thus, tumor 
spheroids induced remote orientation of collagen fibers up to distances of 5 times the spheroid radius.
Remote tumor-induced collagen network reorientation correlates with local cell migration 
capacity and requires Rho kinase-myosin activity. To address the role of collagen-binding integrins 
(mainly α 1β 1, α 2β 1) in tumor-induced collagen orientation we made use of cells stably expressing shRNAs 
targeting ITGB1, causing strongly reduced (~90%) levels of β 1 integrins (Supplementary Fig. S1)17. For 4T1 
Figure 1. 4T1 breast cancer spheroid expansion and collagen network organization. (a,b) 4T1 tumor 
spheroid at the day of injection (a) and 48 hours after injection (b). (c) Spheroid mask covering core spheroid 
and migrating cells at 48 hours, which was used as boundary for collagen organization calculations (red 
dashed circle). (d) Inverted reflection microscopy image with tumor border (red dashed circle) showing radial 
orientation of surrounding collagen.
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cells, depletion of β 1 integrins reduced spheroid expansion through collective migration and caused a switch to 
individual cell migration as described before17 (Fig. 3a). This was accompanied by reduced collagen orientation 
(measured beyond the area of cell migration) (Fig. 3a). Similar results were obtained for HCC70-derived tumor 
spheroids (Supplementary Fig. S1). By contrast, control MDA-MB-468 and BT20 tumor spheroids showed little 
migration whereas depletion of β 1 integrins in these cells enhanced spheroid expansion through a mix of collec-
tive and single cell migration (Fig. 3c and Supplementary Fig. S1). In these cases, depletion of β 1 integrins led to 
an increased remote collagen orientation (Fig. 3d and Supplementary Fig. S1). Lastly, in HCC1806 cells β 1 integ-
rin depletion caused a shift from relatively ineffective collective migration to similarly weak single cell migration 
and this did not affect the capacity of the tumor spheroids to cause collagen orientation (Fig. 3e,f). Together, these 
results indicated that the capacity of tumor cells to orient the collagen network was not affected by a reduction 
in collagen-binding integrins per se. Rather, changes in integrin expression caused decreased or increased tumor 
cell migration at the spheroid edge, which correlated with decreased or increased remote collagen orientation 
capacity, respectively.
We next tested a larger panel of carcinoma and sarcoma cell lines for their capacity to orient surrounding col-
lagen (Supplementary Fig. S2). In line with the results obtained with 4T1 cells, irrespective of the origin of the cell 
line, β 1 integrin expression level, or migration strategy; there was a strong correlation between remote collagen 
orientation capacity and spheroid expansion (average initial spheroid radius for all cell lines was 113 ± 29 μm, 
x-intercept of linear fit was 113 ± 26 μm) (Fig. 4a,b). Measured spheroid expansion included spheroid growth and 
migration. Tumor cell types showing the largest spheroid expansions typically displayed strong migration activity. 
To investigate the role of cytoskeletal contractility, pharmacological inhibition of myosin II or Rho kinase that 
acts upstream of myosin II activity was used for the duration of the experiment. Treatment of 4T1 spheroids with 
Figure 2. 4T1 breast cancer spheroids cause long distance radial orientation of surrounding collagen.  
(a) DIC (top) and reflection microscopy (middle) images of collagen-embedded spheroid 48 hours post 
injection and corresponding collagen orientation detection (bottom; red, radially oriented collagen fibers; 
blue, tangential collagen fibers). Dashed lines note the indicated distances from tumor spheroid border. Note 
the dense red at distance 0–1 mm with gradually increasing randomness of colors at increasing distances. In i 
and ii zoom-ins of the indicated areas are shown. (b) Collagen orientation parameter calculated 48 hours after 
injection at the indicated distances from individual tumor spheroid borders for 29 4T1 injections (black circles) 
and 22 wells lacking tumor spheroids (gray squares) from 5 independent experimental replicas with standard 
deviations. The fit equation (black line) is shown.
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a myosin II inhibitor caused a ~15% decrease in final spheroid radius and reduced collective migration activity 
that was accompanied by a 50% reduction in remote collagen orientation (Fig. 4c,d and Supplementary Fig. 
S3). Inhibition of Rho kinase led to a ~8% decrease in final spheroid radius and caused a switch from collective 
migration to individual cell migration that was accompanied by a 70% reduction in remote collagen orientation 
(Fig. 4c,d and Supplementary Fig. S3). Neither Blebbistatin nor Y-27632 at the concentrations used affected cell 
proliferation (Fig. 4e and Supplementary Fig. S3). These results showed that inhibition of Rho kinase-myosin 
II-mediated contractility has moderate effects on spheroid expansion but strongly attenuates remote collagen 
orientation.
Tumor-oriented collagen network directs endothelial cell migration. HMEC-1 human micro-
vascular endothelial cells were injected at various defined x-y distances from 4T1 spheroids at 48 hours post 
4T1 injection (Fig. 5a and Supplementary Fig. S4). The resulting endothelial spheroids were monitored by DIC, 
24 hours later and the direction of the tumor spheroid was marked (red arrow head) (Fig. 5b). Endothelial sphe-
roid masks were generated to study the orientation of their long axis (Fig. 5c; blue arrows) and relate this to the 
relative position of the tumor spheroid (Fig. 5c; red arrows). Alignment of the endothelial spheroid in the direc-
tion of the tumor spheroid was observed for injections within the 2.65 mm collagen orientation area whereas this 
was lost for endothelial cells injected beyond this zone (Fig. 5d).
Figure 3. Distinct effects of β1 integrin downregulation on tumor spheroid cell migration and collagen 
orientation. (a,c,e) Collagen orientation images merged with DIC images taken 48 hours after injecting the 
indicated cell lines with or without shRNA targeting ITGB1. Collagen image zoom-ins of the indicated black 
boxes 500 μm from the tumor spheroid edge are shown at left top of each image. (b,d,f) Collagen orientation 
measured at a range of distances from tumor border for 4T1 shctrl (b, green; n = 29), 4T1 shITGB1 (b, 
red; n = 29), MDA-MB-468 WT (d, green; n = 16), MDA-MB-468 shITGB1 (d, red; n = 21), HCC1806 
shctrl (f, green; n = 20), and HCC1806 shITGB1 (f, red; n = 21) tumor spheroids 48 hours after injection. 
Mean ± standard deviation with exponential fits (solid lines) from at least four independent experimental 
replicas is shown.
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Next, HMEC-1 cells were injected at varying distances from tumor spheroids derived from the panel of cell 
lines described above (Fig. 6a). The distance to which HMEC-1 cells could sense and respond to these spheroids 
differed in accordance with the large variation in collagen orientation distance among these lines (Fig. 4). Across 
the panel of cell lines, HMEC-1 spheroids present within a zone of strong tumor-oriented collagen were directed 
towards the tumor spheroid whereas direction of HMEC-1 spheroids was random if they were outside of this 
zone (Fig. 6b–d). HMEC-1 directionality was induced in response to collagen orientation significantly above 
average as measured for all tested HMEC-1 injection coordinates (Fig. 6b). This level of orientation was reached 
by 4T1, HCC70, Hs578t, SAOS2, U20S, MOS and KPD but not BT20 or MDA-MB-468 cells. In accordance with 
the data shown above (Fig. 3; Supplemental Fig. S1) β 1 integrin-depletion reduced above-threshold collagen 
orientation measurements for 4T1 and HCC70 cells whereas this was induced for BT20 and MDA-MB-468 cells 
in response to ITGB1 silencing. Likewise, HMEC-1 spheroid elongation correlated with tumor-induced collagen 
orientation (Fig. 6e,f) and combining HMEC-1 spheroid direction and elongation parameters showed a strong 
and significant HMEC orientation response to tumor-oriented collagen (Fig. 6g,h). To rule out differences in the 
production of soluble angiogenic factors as the underlying cause for different efficiencies in triggering HMEC-1 
orientation, we tested the effects of conditioned media derived from the tumor cell lines used. None of the condi-
tioned media, whether obtained from highly effective (e.g. 4T1, SAOS2) or ineffective tumor cell lines (e.g. KPD, 
Figure 4. Tumor induced collagen orientation requires ROCK-myosin II-induced contractility. (a) Table 
showing the fit parameters Y0 and L0, the area under the fitted curve (integrated orientation) and the tumor 
radius 48 hours after injection for indicated cell lines. (b) Graph showing relation between tumor radius at 
48 hours post injection and integrated collagen orientation parameter for cell lines depicted in table a with 
distinct modes of migration as indicated based on DIC images. Plot shows mean, standard deviation and linear 
fit (Y = 0.605( ± 0.06)X-68.65( ± 15.6); R2 = 0.8251). (c,-e) Bar graphs showing mean and standard deviation 
of 4T1 tumor radius 48 h post injection normalized to spheroid size directly after injection (0 h) (c), integrated 
collagen orientation at 48 hours normalized to control (d), and number of nuclei at 0 and 48 h after injection (e) 
for no treatment (Ctrl), 10 μM blebbistatin (bleb) and 10 μM Y27632 (Y27632). NS; p > 0.05 and ***p < 0.0005 
according to Mann-Whitney test (c,e) or unpaired t-test (d) compared to control.
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Figure 5. HMEC-1 microvascular endothelial cells injected within 4T1 remote area of oriented collagen 
show directional migration towards tumor spheroid. (a) Merged DIC/fluorescence images taken at 
t = 72 hours showing CellTracker green CMFDA-labeled HMEC-1 cells injected at t = 48 hours at the  
indicated distances from the spheroid border of CellTracker Orange CMRA-labeled 4T1 cells injected at t = 0. 
(b) Representative DIC images of HMEC-1 spheroids at the day of injection (top) or 24 hours after injection 
(bottom) at indicated distances from 4T1 tumor spheroids, and reflection microscopy images showing collagen 
network at the same location prior to the injection (middle). The red arrows point towards the center of 4T1 
tumor spheroid. (c) HMEC-1 spheroid masks generated for images shown in b (bottom). Blue arrow indicates 
major axis of the mask; red arrow points to 4T1 tumor spheroid center. (d) Major axis orientation of HMEC-1 
spheroids (blue lines) injected at distances from 4T1 spheroid edge less (n = 15; left) or more than 2.63 mm 
(n = 8; right) plotted against the direction of the 4T1 tumor spheroid (set vertically for each experiment; red 
arrow). Data obtained from four independent experiments; P value calculated using Mann-Whitney test.
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Figure 6. Directional HMEC-1 migration towards tumor spheroid when injected within area of tumor-
oriented collagen for panel of tumor cell lines. (a) Panel of cell lines used with corresponding symbols.  
(b,e,g) Direction (b) elongation (e) and orientation (g) of HMEC-1 spheroids measured 24 hours after HMEC-1 
injection at varying distances from panel of tumor spheroids (a) plotted against collagen orientation parameter 
at the corresponding distances (obtained in each case from reflection microscopy 48 hours after tumor cell 
injection just prior to HMEC-1 injection). Dashed line is drawn at one standard deviation above average collagen 
orientation parameter and indicates the threshold for “oriented collagen”. (c,f,h) Box whisker graphs showing 
the minimum to maximum of direction (c) elongation (f) and orientation (h) of HMEC-1 spheroids injected 
in regions of oriented collagen vs regions of random collagen. (d) Major axis direction of HMEC-1 injections 
in oriented collagen vs random collagen plotted against the direction of the tumor spheroids (set vertically 
for each experiment; red arrow). (i) Box whisker graph showing HMEC-1 spheroid expansion following 
24 hours incubation with conditioned medium from the indicated tumor cell lines normalized to complete 
HMEC-1 culture medium (Control); SFM, serum free MCDB131 medium. NS, p > 0.05, *p < 0.05, **p < 0.005, 
***p < 0.0005 according to Mann-Whitney test. PCC: calculated Pearson product-moment correlation coefficient.
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MDA-MB-468) induced HMEC-1 migration above the level observed with standard complete HMEC-1 culture 
medium (Fig. 6i; Supplementary Fig. S4).
Endothelial response to oriented collagen network requires physical coupling with tumor. To 
address if physical connections between the tumor spheroid and the oriented collagen network remained impor-
tant for guidance of endothelial cells, the spheroid was physically disconnected after the collagen network had 
been oriented. For this purpose, two HMEC-1 spheroids were injected at the same distance from the tumor sphe-
roid at opposite sides and laser severing of collagen fibers was applied close to the tumor edge, between the tumor 
and one of the HMEC-1 spheroids (Fig. 7a). Orientation of the collagen network was maintained in areas discon-
nected from the tumor spheroid through laser severing (Fig. 7b,c). However, HMEC-1 cells injected in such areas 
Figure 7. Endothelial response to tumor-oriented collagen network depends on physical connection of 
oriented collagen network with the tumor. (a) Collagen orientation image superimposed on DIC image 
showing 4T1 spheroid (center) and two HMEC-1 spheroids at the top and bottom of the image at ~1.4 mm from 
the 4T1 injection. Yellow asterisk indicates area of laser severing 48 hours post 4T1 injection just after HMEC-1 
injection; red box, area disconnected from the tumor; blue box, control area. In i and ii collagen images for 
zoom-ins of the indicated areas are shown. i’ is the image obtained from the same location as i prior to laser 
severing. (b) Collagen orientation parameter (mean ± standard deviation) for control (blue) and disconnected 
(red) areas. The region where HMEC-1 cells were injected is indicated. (c) Box whisker graphs showing the 
minimum to maximum of collagen orientation parameter at the HMEC-1 injection sites just prior to HMEC-1 
injection for blue box in Fig. a (Ctrl) and red box in Fig. a before and after laser ablation. (d–h) Box whisker 
graphs showing the minimum to maximum of direction (d,g), elongation (e,h) and orientation (f) of HMEC-1 
spheroids injected in oriented or random collagen regions 48 hours after 4T1 injections (black legends; data for 
4T1 cells from Fig. 5) or injected in the blue box (oriented ctrl) or the disconnected red box (oriented cut) as 
indicated in a (d–f) or in absence of tumor cells (g,h) 24 hours after HMEC-1 injection and subsequent laser 
ablation. NS, p > 0.05; *p < 0.05; **p < 0.01; ***p < 0.001 relative to oriented unless otherwise indicated; Mann-
Whitney test.
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no longer responded to collagen orientation: HMEC-1 spheroid direction, elongation, and the combined orienta-
tion parameter were decreased; resembling HMEC-1 behavior in non-oriented collagen areas (Fig. 7d–f). Control 
HMEC-1 spheroids in the same well that were still connected to the tumor normally responded to oriented 
collagen (Fig. 7d–f). As a control, laser ablation in non-oriented collagen did not affect the random HMEC-1 
migration (Fig. 7g,h and Supplementary Fig. S5). These findings demonstrate that an intact physical connection 
of the oriented ECM network with the tumor spheroid is required for orientation sensing by the endothelial cells.
Discussion
The tumor stroma plays an important role in initiation and progression of cancer18. Mechanical properties of 
the ECM can influence tumor cell behavior and have been linked to prognosis. ECM stiffness19–21, pore size22–24, 
crosslinking25, fiber alignment26,27, as well as the presence of stromal contractile cells28 have all been shown to 
influence aspects of cancer progression, including tumor growth and invasion. Vice-versa, tumor cells actively 
modify these ECM properties thereby promoting tumor growth, invasion, and metastasis potential29–32.
Here, we use quantitative reflection microscopy analysis to study remote tumor-mediated collagen network 
orientation. We show that tumor spheroids reorient a surrounding collagen-based ECM network up to five times 
their radius. In a panel of cell lines the distance of collagen orientation correlates with spheroid expansion, which 
is driven by local invasion/migration. Such long range collagen reorganization has also been observed for mouse 
fibroblast explants33. Local ECM reorganization in areas containg tumor cells is driven by Rho kinase-Myosin 
II-mediated contractility19,34,35. Our findings indicate that traction forces applied by the tumor cells on the local 
collagen network drives ECM reorientation also in distant areas where tumor cells are absent. The consequences 
of contractility inhibition for local tumor cell migration are limited. This may be explained by tumor cell plas-
ticity: tumor cells can switch to modes of migration that are less dependent on contractility6–8. By contrast, the 
capacity of a tumor to cause remote ECM reorientation is strongly attenuated under conditions of reduced 
contractility.
Antibody blocking experiments have shown that collagen-binding integrins mediate i) local tumor-induced 
collagen network reorganization36, and ii) tumor cell-responses to mechanical ECM properties25. Gene silencing 
as used in our study may be less efficient than antibody blocking. Nevertheless, we observe highly distinct effects 
of β 1 integrin silencing on collagen network reorientation. We and others have previously shown that depletion 
or blockade of β 1 integrins can either inhibit migration or cause a switch from collective to single cell migration, 
e.g. through effects on TGF-β signaling17,37,38. Our current study shows that in tumors where collective migration 
is attenuated or switched to less abundant individual cell migration in response to β 1 integrin silencing, collagen 
network reorientation is lost (e.g. 4T1); whereas in tumors where cell motility is normally very poor and β 1 inte-
grin silencing triggers more abundant (individual) cell migration, a concomitant increase in collagen network 
reorientation is observed (e.g. MDA-MB-468). The fact that β 1 integrin silencing does not directly attenuate 
collagen organization may point to roles for other collagen-binding receptors. On stromal fibroblasts, syndecan-1 
participates in ECM network alignment39. Likewise, syndecans or discoidin domain collagen receptors on tumor 
cells may be candidates for force-induced collagen reorganization in the context of strongly reduced integrin lev-
els. Moreover, α vβ 3 that is present on MDA-MB-468 and induced on 4T1 cells in response to β 1 integrin silenc-
ing, may be involved through binding cryptic RGD sites in areas where collagen is processesed by tumor cells17,40
Our findings indicate that tumor spheroids can reorient collagen networks at relatively long distances, way 
beyond the area of tumor expansion and migration. Endothelial cells can sense such long-range orientation 
and respond by moving towards the tumor. It is known that mechanical ECM properties, such as density and 
stiffness regulate angiogenesis41–44. This may be explained by changes in the distribution of soluble factors or 
enhanced activity of the receptors for these factors12,45,46. Alternatively, physical aspects of the network may 
instruct endothelial cell behavior. Indeed, we show that tumor-mediated remote radial organization of collagen 
directs human microvascular endothelial cells. The correlation between levels of remote collagen organization 
and induction of endothelial cell directionality holds through for a panel of ~20 different human cancer cell lines. 
Laser severing of collagen fibers close to the tumor does not affect the architecture of the remote collagen network 
but leads to complete loss of endothelial cell responsiveness to such oriented ECM regions. This indicates that 
contact guidance, i.e. a preference for aligned collagen fibers, is insufficient. Rather, once the collagen network 
is organized, distant forces applied to the network by the tumor are critical for sensing and/or responding of 
endothelial cells.
We show that conditioned media from the tumor cell lines used do not enhance migration capacity of the 
endothelial cells beyond the level of migration observed in the presence of complete medium, as used in our 
experimental system. Together with the laser severing experiment, this argues against a mechanism involving 
different levels of secretion of soluble angiogenic factors as the underlying cause for the different efficiencies with 
which the tumor cell lines control endothelial cell migration. Importantly, our study does not oppose the estab-
lished role for soluble factors in tumor angiogenesis. In our experiments, soluble factors potentially modulating 
HMEC-1 migration are present in the HMEC-1 medium in a spatially random manner. Under those conditions, 
collagen network orientation by the tumor spheroid directs endothelial cell migration. In vivo, distant ECM reor-
ganization may act in synergy with paracrine signals produced by the tumor to direct microvascular sprouts 
towards the tumor.
Taken together, our study shows for the first time that a radial collagen network organization generated by 
the tumor relatively far beyond the area of tumor expansion and migration, not only forms migratory highways 
for tumor invasion but can also guide angiogenesis in a manner dependent on tumor generated traction forces. 
In coordination with gradients of soluble factors and matrix remodeling by cells in the tumor microenvironment 
such as cancer-associated fibroblasts, this mechanical interaction might further direct microvascular sprouts 
towards the tumor. Hence, targeting tumor induced ECM remodeling may prevent both tumor invasion and 
angiogenesis.
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Materials and Methods
Cell culture. 4T1 mouse breast cancer cells and BT20, BT549, HCC1806, HCC1937, HCC70, HS578t, 
MDA-MB-453, MDA-MB-468, and SKBR7 human breast cancer cells purchased from the American Type Culture 
Collection or provided by Dr. J Foekens, Erasmus Medical Center, Rotterdam NL47 were grown in RPMI1640 
medium supplemented with 10% fetal bovine serum (GIBCO, USA), 25 U/ml penicillin and 25 μg/ml strepto-
mycin (Invitrogen). Human osteosarcoma cell lines MOS, U2OS, 143B, ZK58, SAOS2, and KPD were described 
previously48 and grown in the same medium. Human Ewing sarcoma cell lines 6647 and CHP100 were provided 
by Dr. P. Hogendoorn, Leiden University Medical Center, Leiden NL, and maintained in IMDM cell culture 
medium (GIBCO) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 μg/ml streptomycin. 
Stable bulk-sorted ITGB1-silenced tumor cell lines were described previously17. HMEC-1 human microvascular 
endothelial cells49 were cultured in MCDB131 medium (GIBCO) supplemented with 15% fetal bovine serum, 
200 mM L-Glutamine, 10 μg/mL epidermal growth factor, 100 μg/mL hydrocortisone, 25 U/ml penicillin and 
25 μg/ml streptomycin. All cells were cultured in a humidified incubator at 37 °C with 5% CO2.
Automated sequential microprinting of tumor- and endothelial cells in ECM scaffolds. Collagen 
type I solution was isolated from rat-tail collagen by acid extraction as described previously50. Collagen was 
diluted to 1 mg/mL in the culture medium containing 0.1 M Hepes (BioSolve) and fixed to pH 7.5 by addition 
of NaHCO3 (stock 440 mM, Merck). 60 μL of this solution was then pipetted into a glass-bottom 96 well plate 
(Greiner) and incubated for 1 hour at 37 °C to polymerize.
Automated injection of cell suspensions into the resulting collagen gels to generate arrays of cell spheroids 
with defined x-y-z position was performed as described, using injection robotics from Life Science Methods, 
Leiden NL (http://www.lifesciencemethods.com)17,51. Tumor spheroids of 113 ± 29 μm initial radius were gen-
erated at 200 μm above the glass surface (average collagen gel height ~1.5 mm) and incubated 48 hours with 
appropriate culture media for each cell line. Subsequently, medium was removed, HMEC-1 cells were injected at 
the same z-position at various defined x-y distances from the tumor spheroid, and wells were further incubated 
with HMEC-1 culture media for 24 hours (Supplementary Fig. S4).
For experiments where tumor spheroids were treated with Myosin II or Rho kinase inhibitors, media was sup-
plemented with blebbistatin (Calbiochem cat. number 203389, Merck KGaA, Darmstadt, Germany) or Y27632 
(Tocris cat. number 1254, Bristol, UK), respectively reaching 10 μM final concentration (medium + gel). For flu-
orescent imaging of 4T1 and HMEC-1, cells were incubated at 37 °C with 1 μM CellTracker Orange CMRA or 
CellTracker Green CMFDA Dye, respectively for 15 minutes prior to injection; or with 1 μg/mL Hoechst 33342.
For experiments where HMEC-1 spheroids were incubated with conditioned media from tumor cell lines, 
100 μL of supernatant from 48 hours of cell culture of indicated cell lines where cells were seeded at ~30% con-
fluency and reached ~95% confluency at the day of extraction, was added on top of the collagen gel following the 
injection of HMEC-1 cells. For controls 100 μL complete HMEC-1 culture medium as used throughout all other 
experiments, or MCDB131 medium supplemented with 25 U/ml penicillin and 25 μg/ml streptomycin was used. 
Images were acquired and expansion was calculated after 24 hours.
Collagen gel imaging. Spheroids were imaged using a Nikon TE2000 confocal microscope equipped with 
a Prior stage controlled by NIS Element Software and with a temperature and CO2-controlled incubator. Frame 
stitching was used when necessary. Differential interference contrast (DIC) images were captured using a charged 
coupled device (CCD) camera with NIS software and 10× dry objective. Reflection microscopy of the entire well 
was performed by 5.4 mm × 5.4 mm stitching of images obtained using a 40× long distance water immersion 
objective by illuminating with a 561 laser coupled with a 561 blocking dichroic mirror for the detection.
Laser severing assay. After injecting HMEC-1 cells on both sides of the tumor spheroid at a distance of 
1650 μm from the tumor spheroid center, laser severing was performed on one side of the tumor spheroid. 16 
lines/second stimulation was applied just outside of the tumor spheroid (~1 mm from the HMEC-1 injection 
site), with infrared laser (Coherent Chameleon Discovery) at 790 nm wavelength at full power (~3000 mW), using 
the 40× long distance water immersion lens, while manually scanning through the z plane until all fibers were 
severed. For control experiments addressing the effect of laser severing in random collagen networks, the same 
procedure was used at ~500 μm from the HMEC-1 injection site in absence of tumor spheroids.
Image analysis. All image analysis was performed using in house written Matlab scripts (Mathworks, 
Natick, MA, USA). DIC images were first put through a median filter to create a background illumination signal 
to which the original images were normalized. Normalized images were blurred and a mask for core detection 
was generated by thresholding for signal lower than two standard deviations below the mean and taking only the 
central binary image. Subsequently, a canny edge detection method was applied to the normalized image to mask 
the outer rim of the spheroid. This mask was dilated to include the area of cell migration and combined with the 
core mask to capture the entire final spheroid.
For nuclei counting, the Hoechst signal obtained over multiple z-stacks spanning the full thickness of the 
injection was summed, passed through a Gaussian low pass filter, and signal that was two standard deviations 
larger than the average of the signal was identified as foreground. Individual nuclei were then identified following 
watershed algorithm.
For reflection image analysis, first a background image was calculated by applying a circular averaging filter of 
10 pixel radius to the original image. This image was then subtracted from the original image and a customized 
rollingball filter was applied to extract fibrillar structures. The filter multiplied the signal with itself and used 
a local thresholding algorithm assigning pixels with squared intensities > 0.5 standard deviations above mean 
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squared intensity within 5 px distance, to a collagen fiber. From this binary image, isolated pixels were removed, a 
binary closure was performed, and structures of > 20 pixels and eccentricity ≥ 0.9 were assigned as fibers.
The directionality of a fiber was quantified by first manually determining the center of the tumor spheroid per 
image, and subsequently calculating for each fiber; the cosine square of the angle between the vector pointing 
from the tumor spheroid to the center of the collagen fiber and the orientation of the collagen fiber. The distance 
of a fiber to the tumor edge was calculated by subtracting the previously determined tumor spheroid radius 
(obtained from the DIC image analysis) from the distance of the fiber center to the tumor spheroid center. Fiber 
orientations were analyzed depending on their distance, in bins of 100 px (67 μm). To this data a two-parameter 
single exponential plateauing at 0.5 was fitted with the equation = − . − + .( )Y (p1 0 5)exp 0 5Xp2  for × (distance) 
larger than 100 μm using GraphPad Prism 6 program (GraphPad Software, La Jolla, CA). Integrated orientation 
was calculated from the fit by taking the integral ∫ − . −
∞ ( )(p1 0 5)exp0 Xp2  d× which yielded the result 
(p1-0.5)*p2.
The collagen organization at the locations of HMEC-1 spheroids that were injected at designated distances 
from tumor center, was determined by quantifying the collagen organization at that distance from the tumor 
spheroid before the HMEC-1 injections were performed. When quantifying collagen orientation for the laser 
severing experiment the collagen organization was quantified both before HMEC-1 injection and after HMEC-1 
injection/laser severing was performed. The HMEC-1 direction was determined by calculating the angle between 
the vector pointing from the HMEC-1 center to the tumor spheroid center and HMEC-1 long axis obtained from 
the injection mask, subtracting this angle from 90 degrees and dividing by 90 degrees so that HMEC-1 directed 
towards the tumor had a direction of 1 and HMEC-1 directed perpendicularly had a direction of 0. The elonga-
tion was calculated by dividing the long axis by the short axis length for the HMEC-1 spheroid mask. Pearson 
product-moment correlation coefficient and linear fit were obtained using GraphPad Prism 6 software. The sphe-
roid orientation was calculated by multiplying the direction with the elongation parameter.
To calculate significance between two conditions, the Mann–Whitney U test was used when comparing distri-
bution data, and unpaired t-test was used when comparing integrated collagen orientation.
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